Plain-English translation of NCT05704361 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This trial is testing a new medication called RO7121932 to treat multiple sclerosis. Researchers want to understand how safe this medication is, how your body processes it, and whether it helps control MS symptoms. The medication will be given either as an injection under the skin or through an IV infusion, depending on which part of the study you join.
Current MS treatments don't work well for everyone, and researchers are looking for new options that may be safer or more effective. This early-stage trial will help determine if this new treatment is a promising candidate for future use in MS patients.
Depending on which part of the study you join, you will receive either a single dose or multiple weekly doses of the medication over several weeks. Some participants will receive the medication as an injection under the skin, while others may receive it through an IV. You will have regular clinic visits for blood tests, physical exams, MRI scans, and check-ins to monitor how you're doing. The entire study may last several months, with some participants followed for longer to track long-term safety.
AI-generated summary from trial data · Aug 22, 2026 · Not medical advice
United States
Belgium
Canada